- Home
- ILMN vs NTRS Comparison
ILMN vs NTRS Comparison
Compare ILMN & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- NTRS
- Stock Information
- Founded
- ILMN 1998
- NTRS 1889
- Country
- ILMN United States
- NTRS United States
- Employees
- ILMN 9300
- NTRS N/A
- Industry
- ILMN Medical Specialities
- NTRS Major Banks
- Sector
- ILMN Health Care
- NTRS Finance
- Exchange
- ILMN Nasdaq
- NTRS Nasdaq
- Market Cap
- ILMN 22.9B
- NTRS 22.3B
- IPO Year
- ILMN 2000
- NTRS N/A
- Fundamental
- Price
- ILMN $144.15
- NTRS $111.16
- Analyst Decision
- ILMN Buy
- NTRS Hold
- Analyst Count
- ILMN 20
- NTRS 13
- Target Price
- ILMN $160.68
- NTRS $100.54
- AVG Volume (30 Days)
- ILMN 2.4M
- NTRS 1.1M
- Earning Date
- ILMN 11-04-2024
- NTRS 01-23-2025
- Dividend Yield
- ILMN N/A
- NTRS 2.70%
- EPS Growth
- ILMN N/A
- NTRS 51.89
- EPS
- ILMN N/A
- NTRS 8.00
- Revenue
- ILMN $4,390,000,000.00
- NTRS $7,857,600,000.00
- Revenue This Year
- ILMN N/A
- NTRS N/A
- Revenue Next Year
- ILMN $4.28
- NTRS $3.06
- P/E Ratio
- ILMN N/A
- NTRS $13.89
- Revenue Growth
- ILMN N/A
- NTRS 16.78
- 52 Week Low
- ILMN $97.36
- NTRS $76.67
- 52 Week High
- ILMN $156.66
- NTRS $111.87
- Technical
- Relative Strength Index (RSI)
- ILMN 52.47
- NTRS 74.87
- Support Level
- ILMN $140.56
- NTRS $106.93
- Resistance Level
- ILMN $146.30
- NTRS $109.54
- Average True Range (ATR)
- ILMN 4.65
- NTRS 1.54
- MACD
- ILMN 0.05
- NTRS -0.03
- Stochastic Oscillator
- ILMN 63.86
- NTRS 88.59
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of Dec. 31, 2023, Northern Trust had assets under custody or administration of $15.4 trillion and assets under management of $1.4 trillion.